+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anticholinergic Drugs Market by Type (Natural, Semisynthetic, Synthetic), Application (Chronic Obstructive Pulmonary Disease, Gastrointestinal Disorders, Overactive Bladder), Route of Administration, Sales Channels - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924707
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anticholinergic Drugs Market size was estimated at USD 5.04 billion in 2023, USD 5.09 billion in 2024, and is expected to grow at a CAGR of 11.67% to reach USD 10.92 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticholinergic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticholinergic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticholinergic Drugs Market, highlighting leading vendors and their innovative profiles. These include Alkermes, Astellas Pharma Inc., Boehringer Ingelheim International GmbH, Dr.Reddy's Laboratories Limited, Flagship Biotech International Pvt. Ltd., GlaxoSmithKline Plc, Grevis Pharmaceuticals Pvt. Ltd., Hikma Pharmaceuticals PLC, Manus Aktteva Biopharma LLP, Merck KGaA, Novartis AG, Omicron Pharma, Pfizer Inc., Sanify Healthcare Private Limited, Sanofi S.A., Steris Healthcare Pvt. Ltd., Sun Pharmaceutical Industries Limited, Taj Pharmaceuticals Limited, and Trumac Healthcare.

Market Segmentation & Coverage

This research report categorizes the Anticholinergic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Natural
    • Semisynthetic
    • Synthetic
  • Application
    • Chronic Obstructive Pulmonary Disease
    • Gastrointestinal Disorders
    • Overactive Bladder
    • Parkinson’s Disease
  • Route of Administration
    • Oral
    • Parenteral
    • Topical
  • Sales Channels
    • Offline
      • Hospitals Pharmacies
      • Retail Pharmacies
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Anticholinergic Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticholinergic Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Anticholinergic Drugs Market?
  4. What is the market share of the leading vendors in the Anticholinergic Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Anticholinergic Drugs Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Anticholinergic Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing risk of chronic disorders among population and need for anticholinergic drugs
5.1.1.2. Growing availability of anticholinergic drugs in online sales channels
5.1.1.3. Expansion of healthcare accessibility and infrastructure across economies
5.1.2. Restraints
5.1.2.1. High cost associated with production of anticholinergic drugs
5.1.3. Opportunities
5.1.3.1. Increasing clinical trials and introduction of improved anticholinergic drugs
5.1.3.2. Rising number of anticholinergic drugs approval rates
5.1.4. Challenges
5.1.4.1. Quality control complexities related to anticholinergic drugs production and transportation
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Anticholinergic Drugs Market, by Type
6.1. Introduction
6.2. Natural
6.3. Semisynthetic
6.4. Synthetic
7. Anticholinergic Drugs Market, by Application
7.1. Introduction
7.2. Chronic Obstructive Pulmonary Disease
7.3. Gastrointestinal Disorders
7.4. Overactive Bladder
7.5. Parkinson’s Disease
8. Anticholinergic Drugs Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Topical
9. Anticholinergic Drugs Market, by Sales Channels
9.1. Introduction
9.2. Offline
9.3.1. Hospitals Pharmacies
9.3.2. Retail Pharmacies
9.3. Online
10. Americas Anticholinergic Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Anticholinergic Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Anticholinergic Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Alkermes
14.1.2. Astellas Pharma Inc.
14.1.3. Boehringer Ingelheim International GmbH
14.1.4. Dr.Reddy's Laboratories Limited
14.1.5. Flagship Biotech International Pvt. Ltd.
14.1.6. GlaxoSmithKline Plc
14.1.7. Grevis Pharmaceuticals Pvt. Ltd.
14.1.8. Hikma Pharmaceuticals PLC
14.1.9. Manus Aktteva Biopharma LLP
14.1.10. Merck KGaA
14.1.11. Novartis AG
14.1.12. Omicron Pharma
14.1.13. Pfizer Inc.
14.1.14. Sanify Healthcare Private Limited
14.1.15. Sanofi S.A.
14.1.16. Steris Healthcare Pvt. Ltd.
14.1.17. Sun Pharmaceutical Industries Limited
14.1.18. Taj Pharmaceuticals Limited
14.1.19. Trumac Healthcare
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ANTICHOLINERGIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTICHOLINERGIC DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. ANTICHOLINERGIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANTICHOLINERGIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANTICHOLINERGIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANTICHOLINERGIC DRUGS MARKET DYNAMICS
FIGURE 7. ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2023 VS 2030 (%)
FIGURE 14. ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ANTICHOLINERGIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ANTICHOLINERGIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ANTICHOLINERGIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ANTICHOLINERGIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTICHOLINERGIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. ANTICHOLINERGIC DRUGS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ANTICHOLINERGIC DRUGS MARKET SIZE, BY SEMISYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ANTICHOLINERGIC DRUGS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. ANTICHOLINERGIC DRUGS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ANTICHOLINERGIC DRUGS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ANTICHOLINERGIC DRUGS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ANTICHOLINERGIC DRUGS MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. ANTICHOLINERGIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ANTICHOLINERGIC DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ANTICHOLINERGIC DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 19. ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 21. ANTICHOLINERGIC DRUGS MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ANTICHOLINERGIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ANTICHOLINERGIC DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 40. CANADA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 44. CANADA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 67. CHINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CHINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 71. CHINA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 72. INDIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. INDIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 76. INDIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. JAPAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. THAILAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 133. EGYPT ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. EGYPT ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 138. FINLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. FINLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 158. ITALY ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ITALY ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 162. ITALY ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 173. NORWAY ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NORWAY ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 178. POLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. POLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 182. POLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 183. QATAR ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 187. QATAR ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 218. TURKEY ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM ANTICHOLINERGIC DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ANTICHOLINERGIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ANTICHOLINERGIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ANTICHOLINERGIC DRUGS MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ANTICHOLINERGIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 233. ANTICHOLINERGIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 234. ANTICHOLINERGIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. ANTICHOLINERGIC DRUGS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alkermes
  • Astellas Pharma Inc.
  • Boehringer Ingelheim International GmbH
  • Dr.Reddy's Laboratories Limited
  • Flagship Biotech International Pvt. Ltd.
  • GlaxoSmithKline Plc
  • Grevis Pharmaceuticals Pvt. Ltd.
  • Hikma Pharmaceuticals PLC
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Novartis AG
  • Omicron Pharma
  • Pfizer Inc.
  • Sanify Healthcare Private Limited
  • Sanofi S.A.
  • Steris Healthcare Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Taj Pharmaceuticals Limited
  • Trumac Healthcare

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.92 Billion
Compound Annual Growth Rate11.6%
Regions CoveredGlobal

Related Topics

Related Reports

Anticholinergic Drugs Global Market Report 2024 - Product Image

Anticholinergic Drugs Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Global Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Forecast 2024-2030 - Product Image

Global Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
2024 Global Forecast for Other Antispasmodics and Anticholinergics, Ataractic Combinations, Belladonna, H2 Blocking Agents, Etc. (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Other Antispasmodics and Anticholinergics, Ataractic Combinations, Belladonna, H2 Blocking Agents, Etc. (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
Parkinson's Disease Treatment - Global Strategic Business Report - Product Image

Parkinson's Disease Treatment - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Anticholinergic Market

Anticholinergic drugs are a class of medications that act on the neurotransmitter acetylcholine in the central nervous system. They are used to treat a variety of conditions, including Parkinson's disease, overactive bladder, and gastrointestinal disorders. Anticholinergics work by blocking the action of acetylcholine, which is responsible for transmitting signals between nerve cells. This can help reduce muscle spasms, improve bladder control, and reduce gastrointestinal symptoms. Anticholinergics are available in both prescription and over-the-counter forms. Commonly prescribed anticholinergics include trihexyphenidyl, benztropine, and oxybutynin. Over-the-counter anticholinergics include diphenhydramine and hyoscyamine. Several pharmaceutical companies produce anticholinergic drugs, including Pfizer, GlaxoSmithKline, Merck, and Novartis. Generic versions of anticholinergics are also available from a variety of manufacturers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.